← Browse by Condition
Medical Condition

apol1 mediated kidney disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06824987 Phase 2
Recruiting

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

Enrollment
96 pts
Location
United States, Unite...
Sponsor
AstraZeneca
View Trial →